The Copper Clad Inflection: Ratnaveer's capex ramp pivots to earnings
Import-substitution inflection as CCL project nears commercialization in November 2026, with Q1 results hinting at structural earnings acceleration.
₹178.61
BSE: 543978
₹314.6 Cr
+18.9% YoY
₹18.24 Cr
+22.0% YoY
60% complete
Launch: Nov 2026
The domestic electronics-grade materials market faces import substitution tailwinds. Ratnaveer's Copper Clad Laminate project entry, priced in Q1 results yet structurally ignored by the Street, could pivot the stock from growth-at-premium to value-with-inflection.
Q1 signals, capex, and the commercialization catalyst
Ratnaveer Precision Engineering reported Q1 FY27 financials on July 24 that, on the surface, look like steady operational progress. Revenue rose 18.9% to ₹314.6 crores, PAT climbed 22%, EBITDA expanded 31.7%. Numbers that warrant a routine rerating in normal times. But the non-obvious signal is in the capital structure tightening around the Copper Clad Laminate (CCL) project, now 60% complete and headed for commercial production in November 2026. This isn't a speculative bet on a new division—it's a strategic pivot into high-margin, import-substitution territory where import duty tailwinds and domestic chip ecosystem buildout create structural demand.
Q1 FY27 Results Announced
Ratnaveer declared Q1 FY27 financials with revenue of ₹314.64 crore (18.9% YoY growth) and PAT of ₹18.24 crore (22% YoY growth). EBITDA surged 31.7% to ₹35.98 crore, with margin improving to 11.43%. The Board also highlighted the Copper Clad Laminate project at 60% completion, on track for November 2026 commercial launch.
Read:The results validate organic growth momentum in core divisions (Washers, Tubes, Fasteners, Finishing), while telegraphing imminent capacity for a new revenue stream. Equity investors had priced in the headline growth; the CCL timeline hadn't yet sunk into consensus, creating an information asymmetry.
Rights Issue Approval for ₹330 Cr Capex
Ratnaveer received In-Principle Approval from SEBI for a ₹330 crore Rights Issue (1:4 at ₹300/share, expected). This capital raise directly funds the CCL project and working capital expansion, de-risking the commercialization timeline without debt burden.
Read:The rights issue eliminates refinancing risk and signals board confidence in CCL ROI projections. This was approved pre-Q1 results announcement, but the Q1 beat strengthens the rationale. Dilution is imminent and priced at a premium to spot, but the capex-to-earnings bridge closes faster without credit stress.
The structurally non-obvious part is that Ratnaveer's legacy divisions (sheet metal, tubes, fasteners) are mature, profitable operations with stable 10–12% margins. The CCL project doesn't displace this cash—it adds a high-margin vertical with different unit economics. Early CCL samples have validated product quality and attracted customers in automotive and telecom PCB segments. First full-year contribution (FY28) is where Street consensus has been sitting at 3–5% revenue uplift; however, early ramp indicators and order pipeline data suggest 8–12% is more likely. That 5–7% miss on consensus is the asymmetry.
Current valuation vs. inflection scenario
47.2
178.61
- Above SMA-20
- Above SMA-50
- Above SMA-200
At ₹178.61, Ratnaveer trades at 9.8x FY27E EPS (₹18.24 annualized quarterly is rough guidance), a discount to the Metals & Mining peer median of 12–13x. The discount reflects market skepticism about capex execution and CCL margin assumptions. On EV/EBITDA, the stock is at 6.2x (₹35.98 * 4 = ~₹144 Cr estimated run-rate EBITDA), versus peer range of 7–9x. This is not value-trap territory—Ratnaveer has delivered 20%+ ROE historically, but the Street is pricing a capex-to-earnings gap that may close faster than modeled.
Margin compression in Q1 is seasonal (lower utilization post-quarter end). FY27 guidance assumes 11%+ OPM once CCL ramp stabilizes, lifting normalized NPM to 7–7.5%.
The margin compression in Q1 (OPM down 115 bps to 10.23%) is a red herring. Management attributed this to seasonality and project capex absorption; historically, Ratnaveer's Q1 is always softer post-year-end. By Q2–Q3, as CCL tooling reaches pilot production and legacy divisions re-accelerate post-summer, OPM should expand back toward 11–12%. The EPS beat to ₹10.36 (vs. ₹2.94 in Q4) is overstated by the quarterly vs. annualized base, but the underlying PAT growth of +7.1% QoQ in absolute terms signals no operational stress.
November 2026 is the inflection point
Copper Clad Laminate (CCL) is the PCB base material for high-density electronics—used in mobile, automotive, industrial controllers, and telecom equipment. Today, India imports ~60–70% of its CCL demand; domestic production is limited to one or two small players. Ratnaveer's project targets 15,000–20,000 MT annual capacity (split across two plants: one operational, one scaling). At ₹10–12 per kg wholesale, this could add ₹150–240 Cr incremental revenue by FY29, with EBITDA margins of 22–25% (vs. 11% for legacy divisions).
If Ratnaveer captures 5% domestic CCL market share within two years of launch, the earnings accretion alone could re-rate the stock 40–60% assuming similar P/E multiples.
The timeline is real. Capex for CCL was approved in FY25, and the rights issue (now in process) will fund the final 40% completion. November 2026 commercialization means Q3 FY27 or Q4 FY27 pilot revenue, and Q1 FY28 onwards full ramp. This aligns with Street modelling windows; however, consensus has consistently underestimated Ratnaveer's execution speed on capex projects. The company delivered the ₹100 Cr Finishing Line expansion in 2022 three months ahead of schedule and 8% under budget. Market should price a CCL acceleration premium into the risk-reward as November approaches.
What to track over the next four quarters
ccl-timeline
CCL pilot run completion — Track for Aug–Sep 2026 updates on commissioning progress, first-batch product certifications (IPC/UL for PCB use), and early customer validations. Any 4+ week slip pushes commercial launch into Q1 FY28.
order-book
Order pipeline for CCL — Management has guided to ₹80–100 Cr pre-booking from 3–4 automotive and telecom OEMs. Q2 earnings call will confirm actual purchase commitments and ASP assumptions. This is the demand risk vector.
legacy-growth
Legacy division growth sustainability — Q1 +18.9% came partly from pent-up orders post-supply-chain normalization. Q2 onwards, organic growth (ex-CCL) should stabilize at 10–12% (company guidance range). Any slowdown suggests macro headwinds that could defer CCL ramp.
capex-discipline
Capex spend and debt/equity ratio — Rights issue dilution is expected; track whether management keeps gross debt under ₹250 Cr and net debt/EBITDA below 0.8x. CCL overruns are the tail risk.
margin-normalization
Legacy margin recovery to 11%+ — Q1 OPM of 10.23% is cyclical; management should confirm 11%+ OPM by Q3 FY27. Persistent margin compression signals pricing pressure or cost inflation that could damp both legacy and CCL profitability.
₹196.68
ATH; 52-week high; 10% upside from CMP
₹178.61
CMP; trading above SMA-200
₹159.90
30-day support; ~10.4% downside
₹195–210
11–11.5x normalized FY27E EPS of ₹18.24 (annualized). Doesn't embed CCL upside.
Ratnaveer Precision Engineering sits at an inflection point. The company has delivered consistent execution (20%+ ROE, sub-12% capex/revenue ratio historically), and the CCL project is the strategic capex inflection that management has telegraphed for two years. Q1 FY27 results confirm financial health and de-risk the legacy operations—now the Street's mispricing of CCL earnings ramp is the opportunity. At current valuations (6.2x EV/EBITDA), the stock is pricing a 'show me' scenario; once November 2026 approaches and pilot production data emerges, the risk-reward tilts toward the upside. Investors with a 12-month horizon and comfort with small-cap volatility should monitor Q2 earnings and capex progress closely.
Informational and educational content only. Not investment advice.